The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro
about
Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)Connexins in neurons and glia: targets for intervention in disease and injuryTherapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver diseaseControl of Kaposi's sarcoma-associated herpesvirus reactivation induced by multiple signalsTanshinone IIA increases the bystander effect of herpes simplex virus thymidine kinase/ganciclovir gene therapy via enhanced gap junctional intercellular communicationThe engineered thymidylate kinase (TMPK)/AZT enzyme-prodrug axis offers efficient bystander cell killing for suicide gene therapy of cancerTargeting of suicide gene delivery in pancreatic cancer cells via FGF receptors.Combination gene delivery of the cell cycle inhibitor p27 with thymidine kinase enhances prodrug cytotoxicityProdrug activation enzymes in cancer gene therapy.Plant thymidine kinase 1: a novel efficient suicide gene for malignant glioma therapyPhase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma.Gap junctions and tumour progression.Sharing signals: connecting lung epithelial cells with gap junction channels.Proposed mechanisms of action for prostate cancer vaccines.Gene therapy of hepatocarcinoma: a long way from the concept to the therapeutical impact.Gap junction coupling is required for tumor cell migration through lymphatic endotheliumGene therapy for malignant glioma.TK gene combined with mIL-2 and mGM-CSF genes in treatment of gastric cancerMonitoring the Bystander Killing Effect of Human Multipotent Stem Cells for Treatment of Malignant Brain Tumors.Oxidative stress, lens gap junctions, and cataractsConnexin43 increases the sensitivity of prostate cancer cells to TNFalpha-induced apoptosis.Strategies in gene therapy for glioblastoma.Glioma virus therapies between bench and bedside.Gap junctions and cancer: communicating for 50 years.Cytotoxic immunotherapy strategies for cancer: mechanisms and clinical development.Connexins: key mediators of endocrine function.Involvement of Fas (CD95/APO-1) and Fas ligand in apoptosis induced by ganciclovir treatment of tumor cells transduced with herpes simplex virus thymidine kinase.Micro-PET/CT monitoring of herpes thymidine kinase suicide gene therapy in a prostate cancer xenograft: the advantage of a cell-specific transcriptional targeting approach.Relationship between the expression of connexin43 and bystander effect of suicide gene therapy in ovarian cancer.Direct evidence for the absence of intercellular trafficking of VP22 fused to GFP or to the herpes simplex virus thymidine kinase.Hapten-directed targeting to single-chain antibody receptors.Selective inhibition of hepatoma cells using diphtheria toxin A under the control of the promoter/enhancer region of the human alpha-fetoprotein gene.Antitumor activity with the HSV-tk-gene-modified cell line PA-1-STK in malignant mesothelioma.Mind the Gaps in Tumor Immunity: Impact of Connexin-Mediated Intercellular Connections.Increased cytotoxicity and bystander effect of 5-fluorouracil and 5-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase.Gene- and viral-based therapies for brain tumorsStimulation of intercellular communication of poor-communicating cells by gap-junction-competent cells enhances the HSV-TK/GCV bystander effect in vitro.Induction of a bystander effect in HeLa cells by using a bigenic vector carrying viral thymidine kinase and connexin32 genes.Bystander effect of purine nucleoside analogues in HSV-1 tk suicide gene therapy is superior to that of pyrimidine nucleoside analogues.Connexin 43-mediated bystander effect in two rat glioma cell models.
P2860
Q24792836-60539B2D-CB69-4CB9-870A-0F5EB52A1556Q26786768-36FFDAFD-31A4-40C7-BBCC-3E03B2DDC427Q28472958-4DA38B2B-AAD0-4D14-8CF5-FF016917479CQ28478842-F62B4D24-464B-4AAC-B1CF-06A16F1568C4Q28534514-E01928A0-0871-42F5-9FB6-0B95E29EEF27Q30689378-5DE05B85-92A0-4F49-B297-7F614BF6AD4AQ31063007-F3610D5C-4619-4B38-9D50-2337475F0462Q33785435-09EB0240-C0C7-4F37-A30E-3F5742001FAEQ33968115-BCDD55A8-C495-4E08-8308-5B88BDC8BA59Q34132910-E1BC328C-56BC-41A3-AC8A-8D37B5812755Q34208293-32EEAC23-5BFC-48AB-93C3-1638EC4EE8F2Q34588622-C19C006E-78F1-406C-A926-9849B4803D81Q34958828-FA5B66B2-82E7-489F-A912-0327538B0AFBQ35174754-0C75BB5F-2C8A-4EE6-A095-5D1BA55ADDF6Q35208038-8AE5369C-0008-4B39-BCA5-F71B2EA84A0DQ35537353-B53F4A9B-D8A7-4E16-BB2C-5BF7FA08EE7BQ35673628-0DF060B3-E1F4-4D72-80E0-0DDBE16C49D3Q36178285-EB4F9351-15DE-4212-B14B-BBB0AED99A04Q36530795-51B22C62-1BA0-43C0-A5FE-7472B0445FACQ37285156-A974544D-8DD5-4A8B-AC02-08AF9502E328Q37368462-5A5773E7-F5AE-4D48-85FC-605ED1E360C3Q37420576-E64D3600-F116-49BA-8648-0E54EE68EEEDQ37580510-195A5275-6158-4745-8978-8FEE3D2BEA12Q37613777-EF7C7507-797B-4F9D-ADB8-E86481916BACQ37861631-CC56FDD2-813D-4D43-B0F6-F345CDE4AC30Q37947566-55CA2C17-626D-4A91-84E6-91534287DC61Q38322056-FE779A2B-DE33-4D89-961A-BBC41CA69ED5Q39516198-E3B615B9-A202-4873-A6C7-6A89E3D22C0EQ40473242-28A866D6-6DD5-498E-882E-6599FBA04836Q40504496-9F9269DB-A7C7-49A5-AEEF-50501BA9FF19Q40573309-FA628BB9-47B5-4253-9FD4-90F0312E2948Q40887725-E45A01B4-ED55-49A9-9A4F-3B6AC589EB28Q41017702-F88908B7-C28F-4EA0-B69F-B741E63E7E62Q41619582-98A85568-BF92-4C73-98DF-7BB210165962Q41897991-7DBB35CE-A762-4A05-B0C2-914115BD3565Q42135456-2A36B3FD-86EA-4FFF-8A9E-A3A4D2BDD734Q43544164-57306298-AA1C-4E08-86B3-774E862D89F4Q43574629-D3D95A1E-0298-4443-A8D7-75D74B83EA9FQ43697442-96FE65BD-8E7B-41EE-A931-E77946CC8015Q45714278-788B48BC-A0CB-4EA6-BD54-21295A90DA03
P2860
The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
The extent of heterocellular c ...... er tumor cytotoxicity in vitro
@ast
The extent of heterocellular c ...... er tumor cytotoxicity in vitro
@en
The extent of heterocellular c ...... er tumor cytotoxicity in vitro
@nl
type
label
The extent of heterocellular c ...... er tumor cytotoxicity in vitro
@ast
The extent of heterocellular c ...... er tumor cytotoxicity in vitro
@en
The extent of heterocellular c ...... er tumor cytotoxicity in vitro
@nl
prefLabel
The extent of heterocellular c ...... er tumor cytotoxicity in vitro
@ast
The extent of heterocellular c ...... er tumor cytotoxicity in vitro
@en
The extent of heterocellular c ...... er tumor cytotoxicity in vitro
@nl
P2093
P2860
P356
P1476
The extent of heterocellular c ...... er tumor cytotoxicity in vitro
@en
P2093
P2860
P304
11071-11075
P356
10.1073/PNAS.92.24.11071
P407
P577
1995-11-01T00:00:00Z